| Product Code: ETC6660746 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Canada Medication Assisted Treatment Market Overview |
3.1 Canada Country Macro Economic Indicators |
3.2 Canada Medication Assisted Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Canada Medication Assisted Treatment Market - Industry Life Cycle |
3.4 Canada Medication Assisted Treatment Market - Porter's Five Forces |
3.5 Canada Medication Assisted Treatment Market Revenues & Volume Share, By Products, 2021 & 2031F |
3.6 Canada Medication Assisted Treatment Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.7 Canada Medication Assisted Treatment Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Canada Medication Assisted Treatment Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Canada Medication Assisted Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the benefits of medication-assisted treatment in Canada |
4.2.2 Rising prevalence of substance abuse disorders in the country |
4.2.3 Supportive government initiatives and policies promoting medication-assisted treatment |
4.3 Market Restraints |
4.3.1 Stigma associated with addiction treatment may hinder adoption rates |
4.3.2 Limited access to healthcare services and specialized treatment centers in certain regions of Canada |
4.3.3 High costs associated with medication-assisted treatment programs |
5 Canada Medication Assisted Treatment Market Trends |
6 Canada Medication Assisted Treatment Market, By Types |
6.1 Canada Medication Assisted Treatment Market, By Products |
6.1.1 Overview and Analysis |
6.1.2 Canada Medication Assisted Treatment Market Revenues & Volume, By Products, 2021- 2031F |
6.1.3 Canada Medication Assisted Treatment Market Revenues & Volume, By Buprenorphine and Naloxone, 2021- 2031F |
6.1.4 Canada Medication Assisted Treatment Market Revenues & Volume, By Naltrexone, 2021- 2031F |
6.1.5 Canada Medication Assisted Treatment Market Revenues & Volume, By Buprenorphine, 2021- 2031F |
6.1.6 Canada Medication Assisted Treatment Market Revenues & Volume, By Methadone, 2021- 2031F |
6.2 Canada Medication Assisted Treatment Market, By Drug Type |
6.2.1 Overview and Analysis |
6.2.2 Canada Medication Assisted Treatment Market Revenues & Volume, By Generics, 2021- 2031F |
6.2.3 Canada Medication Assisted Treatment Market Revenues & Volume, By Branded, 2021- 2031F |
6.3 Canada Medication Assisted Treatment Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Canada Medication Assisted Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Canada Medication Assisted Treatment Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 Canada Medication Assisted Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Canada Medication Assisted Treatment Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Canada Medication Assisted Treatment Market Revenues & Volume, By Rehabilitation Clinics, 2021- 2031F |
6.4.3 Canada Medication Assisted Treatment Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.4 Canada Medication Assisted Treatment Market Revenues & Volume, By Specialty Centers, 2021- 2031F |
6.4.5 Canada Medication Assisted Treatment Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.6 Canada Medication Assisted Treatment Market Revenues & Volume, By Others, 2021- 2031F |
7 Canada Medication Assisted Treatment Market Import-Export Trade Statistics |
7.1 Canada Medication Assisted Treatment Market Export to Major Countries |
7.2 Canada Medication Assisted Treatment Market Imports from Major Countries |
8 Canada Medication Assisted Treatment Market Key Performance Indicators |
8.1 Number of healthcare providers trained in administering medication-assisted treatment |
8.2 Percentage of individuals with substance use disorders receiving medication-assisted treatment |
8.3 Rate of successful treatment outcomes and patient retention |
8.4 Average wait times for individuals seeking medication-assisted treatment |
8.5 Funding allocation towards medication-assisted treatment programs and research in Canada |
9 Canada Medication Assisted Treatment Market - Opportunity Assessment |
9.1 Canada Medication Assisted Treatment Market Opportunity Assessment, By Products, 2021 & 2031F |
9.2 Canada Medication Assisted Treatment Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.3 Canada Medication Assisted Treatment Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Canada Medication Assisted Treatment Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Canada Medication Assisted Treatment Market - Competitive Landscape |
10.1 Canada Medication Assisted Treatment Market Revenue Share, By Companies, 2024 |
10.2 Canada Medication Assisted Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here